黄类药物向癌细胞中自和转移途径的不同分子
Aysooda Hosseinzadeh1, Faezeh Poursoleiman2, Akram Naghdipour Biregani3
1Department of Immunology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
在食物中发现的天然化合物黄类化合物,通过抑制癌细胞转移和复发,在癌症治疗中表现有前途. 这篇评论探讨了黄类药物如何克服治疗耐药性,并诱导癌症细胞死亡.
科学领域:
- 在瘤学瘤学.
- 自然产品 化学 化学
- 分子生物学分子生物学
背景情况:
- 癌症治疗面临着挑战,因为固有的耐药性和瘤复发和转移的可能性.
- 识别针对所有癌细胞类型,包括耐药癌细胞的新型治疗剂,对于改善患者的治疗结果至关重要.
研究的目的:
- 审查黄素作为潜在的抗癌剂的作用.
- 探索癌细胞转移,自和无菌之间的关系.
- 证明黄类药物能够抑制转移并诱导癌细胞死亡的能力.
主要方法:
- 文献综述侧重于癌症转移,自,阿诺基斯和黄类药物的抗癌作用.
- 对现有研究的分析,证明了抗癌进展的黄类机制.
主要成果:
- 黄类药物具有抗癌性质,包括抑制癌细胞转移和复发.
- 黄类药物可以有效地阻止癌细胞转移,并诱导癌细胞的亡 (编程细胞死亡).
- 该综述阐明了癌症治疗的背景下转移,自和阿诺基斯之间的复杂相互作用.
结论:
- 黄类化合物代表了癌症治疗的有前途的自然化合物类.
- 它们能够向转移并诱导细胞死亡的能力表明,克服治疗耐药性的潜力.
- 对黄类药物的进一步研究可能会导致全面癌症治疗的新策略.
更多相关视频
09:59Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy
Published on: May 3, 2013
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Intrinsic Apoptotic Pathway
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Prevention
Some...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
